Technical and economic bases of plant raw materi als medicines intro duction

2017

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.24959/uekj.17.21
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

The article is devoted to promising areas for innovation inKazakhstan’s Pharmacy – create medicines using medicinal plants.Aim. Is to carry out a feasibility study for implementation in production of new herbal medicines with sedative effect.Materials and methods. We used methods of marketing research, as well as economic and statistical analysis methods. The information base for the study were the data of the Kazakh state register of medicines, market research companies, the legal framework for the development and registration of drugs.Results. The structural analysis of the pharmaceutical market inKazakhstan, analysis of consumer preferences in the sedative group medicines showed that the drugs are in strong demand, however, the desired sales volumes and the assortment width for the domestic producer have not yet been achieved. The next stage was the technical and economic reasoning of introduction a new herbal medicines on the basis of Valerian Turkestan and Turkestan motherwort, growing inKazakhstan.Conclusions. The analysis shows that there are no domestic phytodrugs created according to GMP standards and GACP principles in theKazakhstan pharmaceutical market. The technical and economic bases for the production of herbal medicine “Sedocaps” (capsules) showed the economic feasibility of the project and return on investment for three years with minimal investment, within six years – at the maximum.